Saturday, November 12, 2022
- 11:30AM-1:00PM
-
Abstract Number: 0001
12-month Findings of the Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR RCT)
Plenary I- 11:30AM-1:00PM
-
Abstract Number: 0002
Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy
Plenary I- 11:30AM-1:00PM
-
Abstract Number: 0004
mTORC1 Drives the Spectrum of Pathology in Systemic JIA and Macrophage Activation Syndrome
Plenary I- 11:30AM-1:00PM
-
Abstract Number: 0003
Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Sub-group Analysis of a Multi-centre Randomised Controlled Trial
Plenary I- 11:30AM-1:00PM
-
Abstract Number: 0005
The Rheumatology Access Expansion (RAE) Initiative: Improving Rheumatoid Arthritis Care on Navajo Nation Through Primary Care Provider Education
Plenary I- 1:00PM-3:00PM
-
Abstract Number: PP20
‘It Is Due to Stress’ – But Which Type of Stress? Cumulative childhood stress is a risk factor for autoimmune disease
Patient Perspectives Poster- 1:00PM-3:00PM
-
Abstract Number: 0213
“The Best Part Is Feeling Like I Could Go out There and Maybe Really Help Somebody”: Training Peer Coaches to Deliver the Moving Well Total Knee Replacement Telephone-Based Coaching Program
Patient Outcomes, Preferences, and Attitudes Poster I- 1:00PM-3:00PM
-
Abstract Number: 0139
A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira®)
Miscellaneous Rheumatic and Inflammatory Diseases Poster I- 1:00PM-3:00PM
-
Abstract Number: PP09
A Matter of Life and Death: Why Diversity, Equity and Inclusion Matter for Health Care Providers
Patient Perspectives Poster- 1:00PM-3:00PM
-
Abstract Number: 0371
A Phase 2, Double-blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101/Lenabasum in Systemic Lupus Erythematosus, an Autoimmunity Centers of Excellence Study (ALE09)
SLE – Treatment Poster I- 1:00PM-3:00PM
-
Abstract Number: 0479
A Prospective Study Evaluating the Utility of Ultrasound in Monitoring Newly-Diagnosed GCA
Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis- 1:00PM-3:00PM
-
Abstract Number: 0311
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Zunsemetinib, an Investigational Oral MK2 Inhibitor, at 80 Mg and 120 Mg Twice Daily Dose Levels in Healthy Subjects
RA – Treatment Poster I- 1:00PM-3:00PM
-
Abstract Number: 0194
A Survey of Patients with Ehlers Danlos Syndrome and Their Interest in Multidisciplinary Care
Patient Outcomes, Preferences, and Attitudes Poster I- 1:00PM-3:00PM
-
Abstract Number: 0457
A Systematic Literature Review Informing the 2022 Update of the EULAR Recommendations for the Management of ANCA-associated Vasculitis